Overview

Cardioprotective Effects of Cardiopeptides for Injection in Patients With Non-severe Cardiac Disease: a Single-center Randomized Controlled Trial

Status:
Recruiting
Trial end date:
2023-11-25
Target enrollment:
Participant gender:
Summary
The study was a single-center, randomized controlled trial. To explore the cardioprotective effect of cardiopeptide on non-heart disease patients with severe cardiac injury by comparing whether cardiopeptide was used.
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital, Southern Medical University